leisure time -WSS

leisure time

author：comprehensive 2025-09-02 08:20:27 - browse：991

Adam's take main illustration — Molly Ferguson/STAT

Thoughts about Cytokinetics after Wednesday night’s financing announcement:

1. Management is raising $500 million at $51 per share, when the stock was at $45 per share before the aficamtem study readout in December. That’s shocking. Somehow, management has not only removed all the M&A premium from the stock, but much or most of aficamtem’s value, too.

2. Omecamtiv’s resurrection: Are you kidding me? No one thinks bringing back this heart failure drug is a good idea, except management. Making it worse, the terms of the Royalty Pharma loan are, again, shocking. All the risk is borne by Cytokinetics. Royalty, in fact, may do better if omecamtiv fails.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 10 million people disenrolled from Medicaid over past six months

hotspot

WSS

Study: New antibiotic targets gonorrhea as well as last existing drug

MoonLake credibility takes another hit with mid

UCSF medical school apologizes for unethical prisoner experiments

Biogen’s boardroom scandal saddles CEO with first crisis

Medicare solvency divides Republicans at the presidential debate

White House calls on federal agencies to crack down on AI abuses

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

In Memoriam: Notable people who died in 2023

Biden administration begins canceling student loan debt for 804,000 borrowers

Hollywood unions extend contract negotiations for actors

BMS, looking to build heart drug business, turns to AI for diagnosis

Tori Bowie and the unacceptable rates of Black maternal death

BMS, looking to build heart drug business, turns to AI for diagnosis

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare solvency divides Republicans at the presidential debate

Jerome Adams on the need for new antivirals for Covid

Abortion clinic in Cancun will cater to Americans

focus

Megan Rapinoe shares emotional post following US Women's World Cup exit

MoonLake credibility takes another hit with mid

Senate panel clears PBM, hopsital reforms

Biotech incubator Curie.Bio graduates its first startup

STAT Executive Editor Rick Berke on STAT's 8th birthday

Excited delirium, Elijah McClain, and emergency physicians

knowledge

focus

hotspot

knowledge